Ai Li Yeo

1.1k total citations
17 papers, 407 citations indexed

About

Ai Li Yeo is a scholar working on Rheumatology, Immunology and Molecular Biology. According to data from OpenAlex, Ai Li Yeo has authored 17 papers receiving a total of 407 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Rheumatology, 5 papers in Immunology and 4 papers in Molecular Biology. Recurrent topics in Ai Li Yeo's work include Immunodeficiency and Autoimmune Disorders (3 papers), Systemic Lupus Erythematosus Research (3 papers) and Rheumatoid Arthritis Research and Therapies (3 papers). Ai Li Yeo is often cited by papers focused on Immunodeficiency and Autoimmune Disorders (3 papers), Systemic Lupus Erythematosus Research (3 papers) and Rheumatoid Arthritis Research and Therapies (3 papers). Ai Li Yeo collaborates with scholars based in Australia, Singapore and Sweden. Ai Li Yeo's co-authors include Edison T. Liu, Chin‐Yo Lin, Jane S. Thomsen, Say Li Kong, Vinsensius B. Vega, Lance D. Miller, Balraj Doray, Liza A. Vergara, Tang Suisheng and Anders Ström and has published in prestigious journals such as SHILAP Revista de lepidopterología, Genome biology and Annals of the Rheumatic Diseases.

In The Last Decade

Ai Li Yeo

16 papers receiving 402 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ai Li Yeo Australia 7 220 170 77 57 56 17 407
Núria Palau Spain 10 143 0.7× 61 0.4× 40 0.5× 66 1.2× 33 0.6× 13 307
Peter Broad United Kingdom 8 336 1.5× 98 0.6× 159 2.1× 41 0.7× 45 0.8× 9 632
Grethe I.G. Alnæs Norway 16 343 1.6× 144 0.8× 176 2.3× 23 0.4× 197 3.5× 19 579
J. Milliken Australia 10 105 0.5× 197 1.2× 151 2.0× 44 0.8× 92 1.6× 14 379
Michael J. Bolt United States 11 315 1.4× 111 0.7× 106 1.4× 146 2.6× 105 1.9× 22 563
Emma J.D. Padilla Australia 11 126 0.6× 122 0.7× 31 0.4× 23 0.4× 48 0.9× 11 335
Takashi Morizono Japan 11 458 2.1× 188 1.1× 53 0.7× 38 0.7× 299 5.3× 15 777
Cenny Taslim United States 18 615 2.8× 80 0.5× 91 1.2× 38 0.7× 124 2.2× 37 777
Jasna Šinkovec Slovenia 12 267 1.2× 184 1.1× 47 0.6× 99 1.7× 40 0.7× 22 689
M. M. de Jong Netherlands 6 185 0.8× 177 1.0× 91 1.2× 27 0.5× 74 1.3× 7 380

Countries citing papers authored by Ai Li Yeo

Since Specialization
Citations

This map shows the geographic impact of Ai Li Yeo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ai Li Yeo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ai Li Yeo more than expected).

Fields of papers citing papers by Ai Li Yeo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ai Li Yeo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ai Li Yeo. The network helps show where Ai Li Yeo may publish in the future.

Co-authorship network of co-authors of Ai Li Yeo

This figure shows the co-authorship network connecting the top 25 collaborators of Ai Li Yeo. A scholar is included among the top collaborators of Ai Li Yeo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ai Li Yeo. Ai Li Yeo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Yeo, Ai Li & Kevin Winthrop. (2024). Pulmonary Complications of Biological Therapies in Inflammatory and Autoimmune Diseases. Clinics in Chest Medicine. 46(1). 169–183. 1 indexed citations
2.
Sée, J., Jessica Fairley, Ai Li Yeo, Samar Ojaimi, & Eric F. Morand. (2024). Anti‐MDA5 positivity: describing the frequency and spectrum of clinically evident MDA5 disease. Internal Medicine Journal. 54(12). 2061–2066. 1 indexed citations
3.
Yeo, Ai Li, Michelle Leech, Samar Ojaimi, & Eric F. Morand. (2022). Utility of repeat extractable nuclear antigen antibody testing: a retrospective audit. Lara D. Veeken. 62(3). 1248–1253. 4 indexed citations
4.
Koelmeyer, Rachel, Ning Li, Ai Li Yeo, et al.. (2022). Predictors of infection requiring hospitalization in patients with systemic lupus erythematosus: a time-to-event analysis. Seminars in Arthritis and Rheumatism. 57. 152099–152099. 13 indexed citations
5.
Yeo, Ai Li, Samar Ojaimi, Suong Le, Michelle Leech, & Eric F. Morand. (2022). Frequency and Clinical Utility of Antibodies to Extractable Nuclear Antigen in the Setting of a Negative Antinuclear Antibody Test. Arthritis Care & Research. 75(7). 1595–1601. 6 indexed citations
6.
Yeo, Ai Li, et al.. (2021). Routine testing for hyposplenism in a lupus clinic diagnoses; new cases and opportunities for intervention. Lupus. 30(4). 687–688. 1 indexed citations
7.
Yeo, Ai Li, et al.. (2021). Impact of COVID‐19 telehealth on outpatient test completion. Internal Medicine Journal. 51(10). 1614–1618. 1 indexed citations
8.
Wang, Dorothy, Ai Li Yeo, Claire Dendle, et al.. (2020). Severe infections remain common in a real-world rheumatoid arthritis cohort: A simple clinical model to predict infection risk. SHILAP Revista de lepidopterología. 8(3). 133–138. 5 indexed citations
9.
Yeo, Ai Li, Suong Le, Jason J. Ong, et al.. (2020). Utility of repeated antinuclear antibody tests: a retrospective database study. The Lancet Rheumatology. 2(7). e412–e417. 11 indexed citations
10.
Yeo, Ai Li, Rachel Koelmeyer, Rangi Kandane‐Rathnayake, et al.. (2019). Lupus Low Disease Activity State and Reduced Direct Health Care Costs in Patients With Systemic Lupus Erythematosus. Arthritis Care & Research. 72(9). 1289–1295. 22 indexed citations
11.
Yeo, Ai Li, Jason J. Ong, Kathryn Connelly, et al.. (2019). OP0020 LESS IS MORE: ANA-LYSING THE IMPACT OF REPEATED ANTINUCLEAR ANTIBODY TESTING. Annals of the Rheumatic Diseases. 78. 76–77. 1 indexed citations
12.
Yeo, Ai Li, et al.. (2011). A Real-Life Snapshot of the Use and Abuse of Urinary Catheters on General Medical Wards. Infection Control and Hospital Epidemiology. 32(12). 1216–1218. 6 indexed citations
13.
Yeo, Zhen Xuan, et al.. (2009). Inferring Transcription Factor Targets from Gene Expression Changes and Predicted Promoter Occupancy. Journal of Computational Biology. 16(2). 357–368. 4 indexed citations
14.
Nilsson, Maria, Thomas M. Stulnig, Chin‐Yo Lin, et al.. (2006). Liver X Receptors Regulate Adrenal Steroidogenesis and Hypothalamic-Pituitary-Adrenal Feedback. Molecular Endocrinology. 21(1). 126–137. 40 indexed citations
15.
Vega, Vinsensius B., Chin‐Yo Lin, Koon Siew Lai, et al.. (2006). Multiplatform genome-wide identification and modeling of functional human estrogen receptor binding sites. Genome biology. 7(9). R82–R82. 43 indexed citations
16.
Lin, Chin‐Yo, Anders Ström, Vinsensius B. Vega, et al.. (2004). Discovery of estrogen receptor α target genes and response elements in breast tumor cells. Genome biology. 5(9). R66–R66. 243 indexed citations
17.
Yeo, Ai Li & Jonathan R. Lamb. (1995). Manipulating the immune response in allergic disease: targeting CD4 T cells. Trends in biotechnology. 13(5). 186–190. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026